跳至主要内容
临床试验/CTRI/2022/06/043428
CTRI/2022/06/043428招募中2 期

Evaluation of efficacy of Phalatrikadi Ghana Vati in Patients of Non -alcoholic fatty liver disease through reverse pharmacology approach

Dr Piyush Chaudhary0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Ultrasonography (USG) abdomen suggestive of NAFLD with or without symptoms like pain in right upper quadrant/epigastric region of the abdomen, feeling of nausea, and vomiting, loss of appetite, burning sensation in the abdomen.
  • 2.Liver function tests showing raised alanine transaminases (ALT) or aspartate transaminases (AST) levels raised above the normal limits (40IU/L) up to 300 IU/L

排除标准

  • 1. Patients unwilling to participate in study
  • 2. Patients with a history of alcohol intake exceeding 20 g/day (Alcohol consumption history shall be separately obtained from the patients and family)
  • 3. Patients testing positive for markers of other viral hepatitis

研究者

发起方
Dr Piyush Chaudhary

相似试验